PTK2 and renal cell carcinoma: To clarify whether FAK or RhoA can function as a downstream effector of EphA2 in RCC cells, we examined the effect of EphA2 siRNA-mediated knockdown on FAK phosphorylation and expression of membrane-bound RhoA protein in all RCC cell lines (Fig 7).